{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:30:31Z","timestamp":1789939831699,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T00:00:00Z","timestamp":1286928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00280-010-1482-y","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T23:28:22Z","timestamp":1287012502000},"page":"247-253","source":"Crossref","is-referenced-by-count":19,"title":["Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement"],"prefix":"10.1007","volume":"68","author":[{"given":"Apostolia M.","family":"Tsimberidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Letourneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aung","family":"Naing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wheler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"McRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,13]]},"reference":[{"key":"1482_CR1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/02841860151116367","volume":"40","author":"P Ragnhammar","year":"2001","unstructured":"Ragnhammar P, Hafstrom L, Nygren P et al (2001) A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 40:282\u2013308","journal-title":"Acta Oncol"},{"key":"1482_CR2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3816\/CCC.2008.n.032","volume":"7","author":"DG Power","year":"2008","unstructured":"Power DG, Healey-Bird BR, Kemeny NE (2008) Regional chemotherapy for liver-limited metastatic colorectal cancer. Clin Colorectal Cancer 7:247\u2013259","journal-title":"Clin Colorectal Cancer"},{"key":"1482_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.suronc.2007.05.001","volume":"16","author":"VP Khatri","year":"2007","unstructured":"Khatri VP, Chee KG, Petrelli NJ (2007) Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. Surg Oncol 16:71\u201383","journal-title":"Surg Oncol"},{"key":"1482_CR4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s11605-006-0061-3","volume":"11","author":"TM Pawlik","year":"2007","unstructured":"Pawlik TM, Choti MA (2007) Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 11:1057\u20131077","journal-title":"J Gastrointest Surg"},{"key":"1482_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1025875332255","volume":"23","author":"SA Curley","year":"2004","unstructured":"Curley SA, Izzo F, Abdalla E et al (2004) Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev 23:165\u2013182","journal-title":"Cancer Metastasis Rev"},{"key":"1482_CR6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2214\/ajr.181.1.1810253","volume":"181","author":"B Damascelli","year":"2003","unstructured":"Damascelli B, Patelli GL, Lanocita R et al (2003) A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings. AJR Am J Roentgenol 181:253\u2013260","journal-title":"AJR Am J Roentgenol"},{"key":"1482_CR7","first-page":"1365","volume":"21","author":"Y Zhao","year":"2002","unstructured":"Zhao Y, Wang SM, Zhang J (2002) Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion. Ai Zheng 21:1365\u20131367","journal-title":"Ai Zheng"},{"key":"1482_CR8","first-page":"1897","volume":"28","author":"Y Chino","year":"2001","unstructured":"Chino Y, Suzuki Y, Ubukata N et al (2001) Hepatic infusion of docetaxel using PEIT for a patient with stage IV breast cancer. Gan To Kagaku Ryoho 28:1897\u20131899","journal-title":"Gan To Kagaku Ryoho"},{"key":"1482_CR9","first-page":"917","volume":"29","author":"S Iwamoto","year":"2002","unstructured":"Iwamoto S, Gon G, Nohara T et al (2002) A case of liver metastasis of breast cancer successfully treated with paclitaxel infusion into the hepatic artery: an attempt of once weekly regimen. Gan To Kagaku Ryoho 29:917\u2013920","journal-title":"Gan To Kagaku Ryoho"},{"key":"1482_CR10","first-page":"1959","volume":"26","author":"SJ Kim","year":"1999","unstructured":"Kim SJ, Maeura Y, Ueda N et al (1999) A case of hepatic arterial infusion chemotherapy with docetaxel for liver metastasis from breast cancer. Gan To Kagaku Ryoho 26:1959\u20131962","journal-title":"Gan To Kagaku Ryoho"},{"key":"1482_CR11","first-page":"2061","volume":"28","author":"Y Kitagawa","year":"2001","unstructured":"Kitagawa Y, Nakase Y, Ebihara Y et al (2001) A case of multiple liver metastases from breast cancer successfully treated with intra-arterial administration of paclitaxel. Gan To Kagaku Ryoho 28:2061\u20132064","journal-title":"Gan To Kagaku Ryoho"},{"key":"1482_CR12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1148\/radiol.2291021029","volume":"229","author":"CJ Yoon","year":"2003","unstructured":"Yoon CJ, Chung JW, Park JH et al (2003) Transcatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumor. Radiology 229:126\u2013131","journal-title":"Radiology"},{"key":"1482_CR13","first-page":"2076","volume":"29","author":"S Matsui","year":"2002","unstructured":"Matsui S, Tono T, Iwazawa T et al (2002) A case of postoperative hepatic metastasis from gastric cancer responding to hepatic arterial infusion chemotherapy of paclitaxel. Gan To Kagaku Ryoho 29:2076\u20132079","journal-title":"Gan To Kagaku Ryoho"},{"key":"1482_CR14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/07357909909011726","volume":"17","author":"GD Walton","year":"1999","unstructured":"Walton GD, Schreeder MT, Rizzo J et al (1999) Hepatic artery administration of paclitaxel. Cancer Invest 17:118\u2013120","journal-title":"Cancer Invest"},{"key":"1482_CR15","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/cncr.22672","volume":"109","author":"LH Camacho","year":"2007","unstructured":"Camacho LH, Kurzrock R, Cheung A et al (2007) Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer 109:2190\u20132196","journal-title":"Cancer"},{"key":"1482_CR16","unstructured":"http:\/\/ctep.cancer.gov\/"},{"key":"1482_CR17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"1482_CR18","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2005.03.6723","volume":"24","author":"MJ Ratain","year":"2006","unstructured":"Ratain MJ, Eisen T, Stadler WM et al (2006) Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol 24:2505\u20132512","journal-title":"J Clin Oncol"},{"key":"1482_CR19","first-page":"524","volume":"26","author":"NE Kemeny","year":"1999","unstructured":"Kemeny NE, Ron IG (1999) Hepatic arterial chemotherapy in metastatic colorectal patients. Semin Oncol 26:524\u2013535","journal-title":"Semin Oncol"},{"key":"1482_CR20","first-page":"2109","volume":"25","author":"S Oura","year":"1998","unstructured":"Oura S, Sakurai T, Yoshimura G et al (1998) Recurrent squamous-cell lung cancer treated with bronchial-arterial infusion of docetaxel\u2013case report. Gan To Kagaku Ryoho 25:2109\u20132113","journal-title":"Gan To Kagaku Ryoho"},{"key":"1482_CR21","first-page":"323","volume":"29","author":"T Akisada","year":"2002","unstructured":"Akisada T, Harada T, Takemoto T et al (2002) A case of advanced hypopharyngeal carcinoma successfully treated with superselective intra-arterial infusion of docetaxel. Gan To Kagaku Ryoho 29:323\u2013328","journal-title":"Gan To Kagaku Ryoho"},{"key":"1482_CR22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clon.2003.07.003","volume":"15","author":"H Yabuuchi","year":"2003","unstructured":"Yabuuchi H, Kuroiwa T, Tajima T et al (2003) Efficacy of intra-arterial infusion therapy using a combination of cisplatin and docetaxel for recurrent head and neck cancers compared with cisplatin alone. Clin Oncol (R Coll Radiol) 15:467\u2013472","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1482_CR23","doi-asserted-by":"crossref","unstructured":"Tsimberidou AM, Fu S, Ng C et al (2010) A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. Cancer [Epub ahead of print]","DOI":"10.1002\/cncr.25277"},{"key":"1482_CR24","doi-asserted-by":"crossref","unstructured":"Tsimberidou AM, Moulder S, Fu S et al (2010) Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement. Cancer Chemother Pharmacol [Epub ahead of print]","DOI":"10.1007\/s00280-010-1266-4"},{"key":"1482_CR25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1081\/CNV-200026526","volume":"22","author":"T Tono","year":"2004","unstructured":"Tono T, Iwazawa T, Matsui S et al (2004) Hepatic arterial infusion of paclitaxel for liver metastasis from gastric cancer. Cancer Invest 22:550\u2013554","journal-title":"Cancer Invest"},{"key":"1482_CR26","unstructured":"NCT00732836 A phase 1, open label, non-randomized trial of hepatic arterial infusion of Abraxane with a pharmacokinetic study in advanced solid cancer patients with predominant hepatic metastases, http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00732836?term=kurzrock+abraxane&rank=2"},{"key":"1482_CR27","unstructured":"NCT01057264 A phase 1, open label, non-randomized trial of hepatic arterial infusion (HAI) of abraxane in combination with gemcitabine and bevacizumab for patients with advanced cancers metastatic to the liver, http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01057264?term=tsimberidou&rank=7"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1482-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-010-1482-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1482-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T12:51:17Z","timestamp":1559739077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-010-1482-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,13]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1482"],"URL":"https:\/\/doi.org\/10.1007\/s00280-010-1482-y","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,13]]}}}